eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank



1/2021
vol. 8
 
Share:
Share:
more
 
 
abstract:
Case report

Hereditary angioedema type III – case report

Katarzyna Waligóra-Dziwak
1
,
Magdalena Woźniak
1
,
Dorota Jenerowicz
1
,
Zygmunt Adamski
1
,
Magdalena Czarnecka-Operacz
1

1.
Katedra i Klinika Dermatologii, Uniwersytet Medyczny w Poznaniu, Polska
Alergologia Polska – Polish Journal of Allergology 2021; 8, 1: 40–47
Online publish date: 2021/03/23
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Hereditary angioedema (HAE) is a genetically determined disease characterized by recurrent episodes of subcutaneous or submucosal tissue oedema. Failure to respond to the classical treatment of angioedema with antihistamines, glucocorticosteroids as well as adrenaline is highly characteristic for HAE. Three main types of HAE have been described: type I – associated with hereditary reduction of C1 esterase inhibitor plasma concentration, type II – associated with its dysfunction and type III with both C1 inhibitor concentration and activity being within the normal range. We present a case report of a 16-year-old female patient with chronic spontaneous angioedema with normal activity and concentration of C1 inhibitor as well as an updated review of the current knowledge concerning pathophysiology, clinical picture, genetic background and possible treatment options for HAE type III.
keywords:

hereditary angioedema, HAE type III, bradykinin, tranexamic acid

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe